Video Player is loading.
Current Time 0:00
Duration 59:25
Loaded: 0.06%
Stream Type LIVE
Remaining Time 59:25
 
1x

Erreur de média

Une erreur s'est produite lors de la tentative de chargement du support. Veuillez réessayer plus tard.

Réessayer

Rejoignez myPOCacademy, ses cours gratuits
et sont accrédités CPD

JOIN

Présentations

  • Prof. Nicholas Francis

    Prof. Nicholas Francis
    (UK)
    Chair

    Safe reduction of antibiotics for acute exacerbations of chronic obstructive pulmonary disease using CRP point-of-care testing: The findings of the PACE Study.

    English

  • Prof. Rogier Hopstaken

    Prof. Rogier Hopstaken
    (The Netherlands)
    Speaker

    Reduction of antibiotic prescribing at primary care: Evidence of the established role of CRP point-of-care testing.

    English

  • Prof. Ivan Gentile

    Prof. Ivan Gentile
    (Italy)
    Speaker

    The fight against antimicrobial resistance in Italy.

    English

    Italian


Les points de vue et opinions présentés n'engagent que les auteurs. Le contenu de ce webcast est destiné à des fins d'information / éducatives uniquement.

Rejoignez <strong>myPOCacademy</strong>, ses cours <strong>gratuits</strong><br>et sont <strong>accrédités CPD</strong>

JOIN

Background

Join our panel of experts from across Europe to learn about the value of C-reactive protein (CRP) point-of-care testing (POCT) to help fight antimicrobial resistance and as an aid to help avoid the misuse of antibiotics. 90% of respiratory tract infections (RTIs) are viral and therefore antibiotics have no clinical benefit. And yet RTIs are one of the most common reasons for unnecessary antibiotic prescribing [1]. The webinar will analyse studies and present front-line experience on the value of CRP POCT told through the eyes of internationally acclaimed healthcare professionals and academics from the UK, the Netherlands and Italy.


Les points de vue et opinions présentés n'engagent que les auteurs. Le contenu de ce webcast est destiné à des fins d'information / éducatives uniquement.

  1. CDC. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Update 27. Oct 2020. Downloaded June 2021. https://stacks.cdc.gov/view/cdc/89980

<strong>&copy; 2023 Abbott. All rights reserved.</strong> All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model. Products available in select markets only. COL-00000

Rejoignez <strong>myPOCacademy</strong>, ses cours <strong>gratuits</strong><br>et sont <strong>accrédités CPD</strong>

JOIN